Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C

NCT06821503 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Pancreatic Cancer

Interventions

DRUG: LM-108 injection
DRUG: Penpulimab injection
DRUG: Paclitaxel for injection (albumin bound)
DRUG: Gemcitabine hydrochloride for injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.